Wen Ting, Shayota Brian J, Wallace Lauren, Mani Coumarane, Davis Neal, Zhao Jian
Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA.
ARUP Laboratories, Salt Lake City, Utah 84108, USA.
Case Rep Genet. 2024 Nov 27;2024:1912620. doi: 10.1155/crig/1912620. eCollection 2024.
Heterozygous microdeletions at 13q12.3 are associated with a rare genetic disorder, 13q12.3 microdeletion syndrome, characterized by intellectual disability, microcephaly, development delay, facial dysmorphisms, atopy, and obesity. Reported 13q12.3 microdeletions vary in size and typically encompass multiple genes. Previous studies have defined a minimal overlap region of 13q12.3 microdeletions and suggested that most of the phenotype associated with the 13q12.3 microdeletion syndrome could be attributed to the loss of the high mobility group box 1 ( gene within the overlap region. Here, we report a pediatric patient who had typical phenotypic features of 13q12.3 microdeletion syndrome, including motor and moderate speech developmental delays, microcephaly, and severe atopy, along with anxiety and aggressive behaviors. Trio-based microarray analysis identified a 62-kb apparently heterozygous deletion at 13q12.3 in the proband, fully encompassing all coding exons of the gene yet not affecting any other neighboring genes. This case report presents a rare single-gene deletion in a patient with classic features of 13q12.3 microdeletion syndrome, allowing a better delineation of clinical phenotypes associated with the loss of . Our findings, together with previous reports, strongly support the pathogenic role of haploinsufficiency in the 13q12.3 microdeletion syndrome.
13q12.3处的杂合微缺失与一种罕见的遗传疾病——13q12.3微缺失综合征相关,其特征为智力残疾、小头畸形、发育迟缓、面部畸形、特应性和肥胖。报道的13q12.3微缺失大小各异,通常包含多个基因。先前的研究已确定了13q12.3微缺失的最小重叠区域,并表明与13q12.3微缺失综合征相关的大多数表型可能归因于重叠区域内高迁移率族框1()基因的缺失。在此,我们报告一名儿科患者,其具有13q12.3微缺失综合征的典型表型特征,包括运动和中度语言发育迟缓、小头畸形和严重特应性,以及焦虑和攻击性行为。基于三联体的微阵列分析在先证者的13q12.3处鉴定出一个62kb的明显杂合缺失,完全涵盖了基因的所有编码外显子,但未影响任何其他相邻基因。本病例报告展示了一名具有13q12.3微缺失综合征典型特征患者中的罕见单基因缺失,从而能更好地描绘与缺失相关的临床表型。我们的发现与先前的报道一起,有力地支持了单倍剂量不足在13q12.3微缺失综合征中的致病作用。